바이오닉 아이 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 : 유형별, 최종사용자별, 지역별, 경쟁(2020-2030년)

The Global Bionic Eye Market was valued at USD 322.15 Million in 2024 and is projected to reach USD 612.09 Million by 2030, growing at a CAGR of 11.25% during the forecast period. This emerging sector is at the forefront of medical device and neuroprosthetics innovation, driven by advances in biotechnology, artificial intelligence, and neural engineering. Bionic eyes-ranging from retinal implants to brain-machine interfaces-aim to restore partial vision in individuals suffering from profound visual impairment or permanent blindness. Increasing technological sophistication, expanding clinical research, and rising prevalence of incurable vision loss are all contributing to the market's acceleration. The integration of AI-driven imaging, wireless connectivity, and machine learning is further enhancing device performance and user outcomes. As the clinical scope extends from retinal conditions to broader neurological impairments, the bionic eye market is poised for transformative growth in both patient impact and commercial opportunity.

Key Market Drivers

Rising Prevalence of Vision Loss and Untreatable Blindness

The increasing incidence of irreversible vision loss due to inherited retinal diseases, age-related macular degeneration (AMD), glaucoma, and optic nerve atrophy is a primary factor fueling demand for bionic eye systems. These conditions frequently progress to stages where existing treatments-such as medications, surgeries, or laser therapies-fail to preserve or restore sight. Globally, more than 1.5 million individuals are affected by hereditary retinal disorders, and approximately 43 million people were estimated to be completely blind in 2020. With aging populations and lifestyle-related health risks such as diabetes on the rise, the global burden of blindness is expected to increase. Bionic eye technologies, including retinal prostheses and neural implants, provide an alternative approach by transmitting visual data directly to the brain or bypassing damaged retinal cells. For patients who no longer respond to conventional therapies, these systems represent a critical solution, filling a treatment void and offering new hope for functional visual recovery.

Key Market Challenges

High Development and Deployment Costs

The complexity of bionic eye systems-requiring cutting-edge microelectronics, neurosensory interfaces, and high-precision surgical procedures-results in substantial development and operational costs. Total treatment costs, including device implantation, patient rehabilitation, and post-operative support, often place the technology beyond the reach of many healthcare providers and patients, particularly in low- and middle-income regions. Limited insurance reimbursement further hinders accessibility. This cost barrier has slowed the pace of adoption and restricted market entry primarily to specialized centers in high-income countries, impeding broader market penetration.

Key Market Trends

Advancements in Brain-Machine Interface (BMI) and Neuroprosthetics

A transformative trend in the bionic eye market is the integration of brain-machine interface technologies, which allow direct communication between external image sensors and the visual cortex. This bypasses damaged optic nerves or retinal pathways, enabling potential restoration of higher-order visual functions such as object identification and spatial awareness. Innovations in electrode array design, neural decoding algorithms, and bio-compatible materials are supporting the development of more natural and responsive visual systems. As these advancements gain traction, next-generation bionic eye devices are evolving beyond basic light detection to provide richer, more functional visual experiences-attracting growing interest from researchers, investors, and medical institutions.

Key Market Players

• Second Sight Medical Products LLC
• Nidek Co. Ltd.
• Nano Retina Ltd.
• MetaModal LLC
• Biomedical Technologies S.L.
• Bionic Vision Technologies
• Pixium Vision
• Monash Vision Group

Report Scope:

In this report, the Global Bionic Eye Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Bionic Eye Market, By Type:

• External Eye
• Implanted Eye

Bionic Eye Market, By End User:

• Hospitals
• Outpatient Facilities
• Research and Manufacturing

Bionic Eye Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Bionic Eye Market.

Available Customizations:

Global Bionic Eye market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Bionic Eye Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (External Eye, Implanted Eye)
  • 5.2.2. By End User (Hospitals, Outpatient Facilities, Research and Manufacturing)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Bionic Eye Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By End User
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Bionic Eye Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By End User
  • 6.3.2. Canada Bionic Eye Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By End User
  • 6.3.3. Mexico Bionic Eye Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By End User

7. Europe Bionic Eye Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By End User
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Bionic Eye Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By End User
  • 7.3.2. United Kingdom Bionic Eye Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By End User
  • 7.3.3. Italy Bionic Eye Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By End User
  • 7.3.4. France Bionic Eye Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By End User
  • 7.3.5. Spain Bionic Eye Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By End User

8. Asia-Pacific Bionic Eye Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By End User
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Bionic Eye Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By End User
  • 8.3.2. India Bionic Eye Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By End User
  • 8.3.3. Japan Bionic Eye Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By End User
  • 8.3.4. South Korea Bionic Eye Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By End User
  • 8.3.5. Australia Bionic Eye Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By End User

9. South America Bionic Eye Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By End User
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Bionic Eye Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By End User
  • 9.3.2. Argentina Bionic Eye Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By End User
  • 9.3.3. Colombia Bionic Eye Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By End User

10. Middle East and Africa Bionic Eye Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By End User
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Bionic Eye Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By End User
  • 10.3.2. Saudi Arabia Bionic Eye Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By End User
  • 10.3.3. UAE Bionic Eye Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Bionic Eye Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Second Sight Medical Products LLC
  • 14.1.1. Business Overview
  • 14.1.2. Product & Service Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (If Listed)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. Nidek Co. Ltd.
• 14.3. Nano Retina Ltd.
• 14.4. MetaModal LLC
• 14.5. Biomedical Technologies S.L.
• 14.6. Bionic Vision Technologies
• 14.7. Pixium Vision
• 14.8. Monash Vision Group

15. Strategic Recommendations

16. About Us & Disclaimer